HK1057474A1 - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number
HK1057474A1
HK1057474A1 HK04100314A HK04100314A HK1057474A1 HK 1057474 A1 HK1057474 A1 HK 1057474A1 HK 04100314 A HK04100314 A HK 04100314A HK 04100314 A HK04100314 A HK 04100314A HK 1057474 A1 HK1057474 A1 HK 1057474A1
Authority
HK
Hong Kong
Prior art keywords
medicinal composition
medicinal
composition
Prior art date
Application number
HK04100314A
Other languages
English (en)
Inventor
Hiroshi Kikuchi
Michiko Iketani
Hideo Kobayashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of HK1057474A1 publication Critical patent/HK1057474A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK04100314A 2000-09-19 2004-01-15 Medicinal composition HK1057474A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000283565 2000-09-19
PCT/JP2001/008137 WO2002024167A1 (fr) 2000-09-19 2001-09-19 Composition medicinale

Publications (1)

Publication Number Publication Date
HK1057474A1 true HK1057474A1 (en) 2004-04-08

Family

ID=18767909

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100314A HK1057474A1 (en) 2000-09-19 2004-01-15 Medicinal composition

Country Status (12)

Country Link
US (2) US20040022848A1 (ru)
EP (1) EP1319399A1 (ru)
JP (3) JPWO2002024167A1 (ru)
KR (1) KR20030040389A (ru)
CN (1) CN1247188C (ru)
AU (1) AU2001290239A1 (ru)
CA (1) CA2419434A1 (ru)
HK (1) HK1057474A1 (ru)
NO (1) NO20031246L (ru)
RU (1) RU2281757C2 (ru)
TW (1) TWI290053B (ru)
WO (1) WO2002024167A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20060153915A1 (en) * 2003-01-23 2006-07-13 Amorepacific Corporation Sustained-release preparations and method for producing the same
DE10323759A1 (de) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen
JP4808392B2 (ja) * 2003-09-04 2011-11-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 苦味を隠蔽する薬理組成物
WO2006059716A1 (ja) * 2004-12-03 2006-06-08 Takeda Pharmaceutical Company Limited 固形製剤
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
WO2006125132A2 (en) * 2005-05-18 2006-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20070224323A1 (en) * 2006-03-23 2007-09-27 Fred Goldman Sugar Replacement and Baked Goods and Caramels Using the Sugar Replacement
ES2602784T3 (es) 2007-02-23 2017-02-22 Gilead Sciences, Inc. Moduladores de las propiedades farmacocinéticas de los agentes terapéuticos
JP2011153075A (ja) * 2008-04-04 2011-08-11 Shionogi & Co Ltd 水懸濁性を向上させた細粒剤
AU2009242451C1 (en) * 2008-05-02 2017-05-18 Gilead Sciences, Inc. The use of solid carrier particles to improve the processability of a pharmaceutical agent
EP2346509B1 (en) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation of levofloxacin for reducing lung inflammation
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
NZ598484A (en) 2009-09-04 2014-02-28 Mpex Pharmaceuticals Inc Use of aerosolized levofloxacin for treating cystic fibrosis
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
US10842802B2 (en) * 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
PT108978B (pt) * 2015-11-24 2020-03-09 Hovione Farm S A Sais de tetraciclinas

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3130058B2 (ja) * 1991-02-15 2001-01-31 第一製薬株式会社 マスクされた粒状物
JP2915590B2 (ja) * 1991-02-15 1999-07-05 第一製薬株式会社 マスクされた粒状物
JP2915653B2 (ja) * 1991-11-14 1999-07-05 第一製薬株式会社 マスクされた粒状物
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
US5688510A (en) * 1993-11-18 1997-11-18 Nippon Shinyaku Co. Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
ATE352289T1 (de) * 1995-05-02 2007-02-15 Taisho Pharmaceutical Co Ltd Mittel zur oralen verabreichung
JPH0995439A (ja) * 1995-09-29 1997-04-08 Eisai Co Ltd 固形製剤の製造方法
JP3126683B2 (ja) * 1996-04-16 2001-01-22 武田薬品工業株式会社 Ｄ−マンニトールおよびその製造法
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
HUP9902165A3 (en) * 1996-04-16 2001-01-29 Bayer Ag D-mannit and with big specific surface area process for preparing it and solid pharmaceuticals containing it
WO1998053802A1 (en) * 1997-05-30 1998-12-03 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
CA2367373C (en) * 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
JP2001270821A (ja) * 2000-03-23 2001-10-02 Eisai Co Ltd 服用感が優れた散剤
JP2001302497A (ja) * 2000-04-21 2001-10-31 Eisai Co Ltd 混合性に優れた散剤

Also Published As

Publication number Publication date
JP2012158610A (ja) 2012-08-23
US20070196504A1 (en) 2007-08-23
EP1319399A1 (en) 2003-06-18
US20040022848A1 (en) 2004-02-05
JP2014132022A (ja) 2014-07-17
AU2001290239A1 (en) 2002-04-02
CN1247188C (zh) 2006-03-29
RU2281757C2 (ru) 2006-08-20
NO20031246D0 (no) 2003-03-18
NO20031246L (no) 2003-03-18
CN1455665A (zh) 2003-11-12
KR20030040389A (ko) 2003-05-22
JPWO2002024167A1 (ja) 2004-01-29
CA2419434A1 (en) 2003-02-07
WO2002024167A1 (fr) 2002-03-28
TWI290053B (en) 2007-11-21

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
GB2358582B (en) Pharmaceutical compositions
HUP0204555A3 (en) Pharmaceutical composition
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
HK1065257A1 (en) Medicinal composition
AU8576801A (en) Pharmaceutical compositions
HK1057474A1 (en) Medicinal composition
GB0002386D0 (en) Therapeutic composition
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0114746D0 (en) Medicinal composition
AU8254101A (en) Medicinal compositions
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0008872D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090919